Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

por Brümmendorf, Tim H, Cortes, Jorge E, de Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M, Gambacorti-Passerini, Carlo
Publicado 2015

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia

por Pautas, Cécile, Raffoux, Emmanuel, Lambert, Juliette, Legrand, Ollivier, Chantepie, Sylvain, Gastaud, Lauris, Marolleau, Jean-Pierre, Thomas, Xavier, Turlure, Pascal, Benner, Rebecca J., Vandendries, Erik, Gogat, Karïn, Dombret, Hervé, Castaigne, Sylvie
Publicado 2021